Pursuant to Regulation 47 of SEBI Listing Regulations, 2015, copies of newspaper publication of Unaudited Financial Results for the quarter & nine months ended December 31, 2025 is attached herewith
GAUDIUMIVF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gaudium IVF and Women Health Limited has submitted copies of newspaper advertisements published on March 19, 2026 in Financial Express and Jansatta, as required under SEBI Listing Regulations. The advertisements relate to the company's unaudited financial results for the quarter and nine months ended December 31, 2025, which were approved by the Board on March 18, 2026 on both standalone and consolidated basis. The filing is a routine regulatory compliance disclosure and does not contain new financial information beyond what was already approved. Revenue from operations for Q3 FY26 stood at approximately Rs. 35.73 crore and Rs. 85.10 crore for the nine-month period. The full results along with the Limited Review Report are available on the company's website and on the BSE and NSE websites.
This is a procedural compliance filing confirming that the company has publicly disclosed its Q3 FY26 results through newspaper advertisements as mandated by SEBI. There is no new business or financial information beyond what was already disclosed when the Board approved the results on March 18, 2026, so investors should refer to the original results announcement for actionable details.